Navigation Links
Finally, The First Ever Treatment for Drug-Resistant HIV

ding to research results.

"In Phase 3 clinical trials of TMC-114, the majority of patients receiving the drug did very well with relatively few side effects," Mitsuya said. "Those patients showed a significant increase in their CD4 cell counts. Many of those patients have been treated for a year or more and have shown no signs of developing a significant resistance to the drug."

Ghosh is now expanding on his design, making alterations to the original molecule aimed at making even more effective treatments. "The most recent protease inhibitors we created are exceedingly potent," he said. Ghosh's work has opened the door to a new path for antiretroviral therapy.

"Earlier, researchers were unsure of how to deal with drug-resistant viruses," he said. "Problems that arose with treatments developed in the 1990s were disheartening. There was no concept on the horizon. We created a conceptually new class of protease inhibitors to combat drug resistance. That has renewed excitement in antiretroviral treatment and provided a direction for the future." These new protease inhibitors are beneficial for reasons beyond their potency and enduring effectiveness, Ghosh said.

"Because they are synthetic, lab-created materials, they are amenable to cost-effective mass production. Keeping costs down greatly increases the accessibility of the drugs to Third World countries where the epidemic is worst."

The design, synthesis and evaluation of these new protease inhibitors will be detailed in a paper in the Aug. 24 issue of the Journal of Medicinal Chemistry and is currently available on the journal's Web site.

Irene Weber of Georgia State University, Eric Walters of Rosalind Franklin University of Medicine and Mitsuya co-authored the papers with Ghosh. Mitsuya characterized the molecules' effectiveness and Walters and Weber performed the crystallography that provided images of the molecules' structures.
<
'"/>




Page: 1 2 3 4

Related medicine news :

1. Finally, light at the end of the tunnel for those suffering tunnel vision
2. First Vaccine Designed for Africa Cleared for Testing in Humans
3. Ajanta Launches Worlds First Once-A-Day Nimesulide Oral Formulation
4. First human clone is near
5. First Artificial Heart patient has Major setback
6. First head-to-head trials of once weekly Fosamax and Actonel therapies
7. WHO Declares Vietnam First Country to Control SARS
8. Russia Reports First SARS Case
9. Hope for First New Melanoma Treatment in Decades
10. First global SARS meet opens
11. Stanford Medical Center Implements The First Virtual Cardiac Ultrasound
Post Your Comments:
*Name:
*Comment:
*Email:
TAG: Finally The First Ever Treatment for Drug Resistant HIV

(Date:9/17/2014)... is available in Spanish . ... than half of the population in our Community. Excess ... which affects liver function. Fat accumulates in the liver ... fibrosis and finally, cirrhosis. To date, the most reliable ... Imaging techniques such as abdominal ecography detect it but ...
(Date:9/17/2014)... West Orange, NJ. September 17, 2014. Kessler Foundation ... grants awarded by the International Progressive Multiple Sclerosis ... Neuropsychology, Neuroscience & Traumatic Brain Injury Research, is ... at the efficacy of cognitive rehabilitation in individuals ... of 22 research grants awarded by the Alliance ...
(Date:9/17/2014)... International Journal of Surgery ( IJS ) has announced ... content: after 24 months published journal issues become available for ... is to improve surgical knowledge and patient care and ... all will improve efforts to achieve this. , Professor ... has always been a great place for authors to publish ...
(Date:9/17/2014)... 2014 Elsevier, a world-leading provider of scientific, ... announced the publication of a position statement by ... the journal Maturitas on the topic ... the most prevalent cancer in women, with slightly ... Western countries. Mammography screening is a well-established method ...
(Date:9/17/2014)... (GSA) invites all journalists to attend its 67th ... conference in the field of aging from November ... register free of charge. , An estimated 4,000 professionals ... Walter E. Washington Convention Center and Marriott Marquis Washington, ... Cells to Societies" and the program schedule contains more ...
Breaking Medicine News(10 mins):Health News:Magnetic resonance helps to detect and quantify fat in liver 2Health News:Kessler Foundation receives first-round grant from International Progressive Multiple Sclerosis Alliance 2Health News:Join GSA in Washington, DC, for the Nation's Premier Aging Conference 2
... genetic disease that causes deafness and dumbness has hit a ... victims belong to Gujjar community. // ,Health and Medical ... that at least 72 cases of the disease have surfaced ... New born babies are also affected by the disease" ...
... the brain of mice were augmented, conditions similar to ... was reported by researchers from Stanford University Medical Centre ... in the treatment of this disease in humans. According ... a drug along with cannabis-like chemicals resulted in a ...
... genetic disease, genetics researchers have identified a novel biological ... development, potentially in cases of mental retardation and autism. ... two genes that contribute to Cornelia deLange syndrome (CdLS), ... in 10,000 children. The disease varies from milder to ...
... by x-ray crystallography. The bundle contains eight copies of ... like and unlike colors, respectively. ,Researchers ... found in natural proteins, discovering that they can form ... protein. Their findings could help scientists design drugs that ...
... According to one of the major findings of a ... less than children who sleep less, and they //are ... years later. The results of this new study were ... Child Development. ,Conducted by researchers at ...
... artemisinin-based combination therapies to prevent malaria //parasites from developing ... the National Agency for Food and Drug Administration and ... the parasite already has grown resistant to chloroquine and ... be difficult to find another malaria treatment. ...
Cached Medicine News:Health News:Gene Found for Rare Disorder May Reveal New Pathway in Mental Retardation 2Health News:Man-Made Proteins Could Be More Useful Than Real Ones 2Health News:Man-Made Proteins Could Be More Useful Than Real Ones 3Health News:Childhood Obesity Linked With Sleep 2
(Date:9/17/2014)... 2014  The law firm McElroy, Deutsch, Mulvaney ... will serve as host for "Show Me the ... of Healthcare Reform," a one-day conference scheduled for ... reimbursement, compliance and enforcement in a marketplace re-shaped ... Logo -  http://photos.prnewswire.com/prnh/20140916/146606 Logo -  http://photos.prnewswire.com/prnh/20140916/146607 ...
(Date:9/17/2014)... ANGELES and LEIPZIG, Germany ... today announced that it has entered into an ... the development of antibody-based imaging agents to image ... "Our collaboration with Novotectid expands ImaginAb,s capability to precisely ... immune-oncology and autoimmune disease areas. The ability to ...
(Date:9/17/2014)...   GS1 US has published a ... to support the 2013 Drug Supply Chain Security ... in the pharmaceutical supply chain. The document, titled ... Supply Chain Business Processes to Support the Drug ... in collaboration with GS1 Healthcare US®, a GS1 ...
Breaking Medicine Technology:Three Leading Healthcare Organizations Sponsor Conference to Examine Opportunities and Risks of Healthcare Reform for Providers 2ImaginAb Expands ImmunoPET Pipeline to Include CD4+ T-Cell Imaging 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 2New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 3New Healthcare Industry Guideline Delineates How to Implement GS1 Standards to Support Requirements of the 2013 Drug Supply Chain Security Act 4
... Results Further Validate Lipidomic-Based Therapeutics as an Emerging Area ... ... DIEGO, Sept. 4 Lpath, Inc. (OTC Bulletin,Board: LPTN), the ... in several murine models of human cancer,and AMD with Lpathomab(TM), ...
... HistoRx AQUA(R)-based assays to evaluate, clinical utility of protein ... ... -, NEW HAVEN, Conn., Sept. 4 HistoRx, Inc., ... the Radiation,Therapy Oncology Group (RTOG), a National Cancer Institute-funded clinical,cooperative ...
Cached Medicine Technology:Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 2Lpath Demonstrates Preclinical Efficacy of Lpathomab(TM) and Initiates Humanization Process 3HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 2HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership 3
... CLIP 5 mm clip applier contains ... designed for introduction and use through ... sleeve, or larger with the use ... of the shaft is approximately 28 ...
Pilling-Weck, medium-large clip size, 10mm, rotatable take apart...
Insert only, Ethicon medium-large clip size...
Ethicon, medium-large clip size, 10mm, rotatable take apart...
Medicine Products: